Corrigendum to "Genetic diversity of next generation antimalarial targets: A baseline for drug resistance surveillance programmes" [Int. J. Parasitol. Drugs and Drug Resist. 7 (2017) 174-180].

Ana Rita Gomes; Matt Ravenhall; Ernest Diez Benavente; Arthur Talman; Colin Sutherland ORCID logo; Cally Roper ORCID logo; Taane G Clark ORCID logo; Susana Campino ORCID logo; (2017) Corrigendum to "Genetic diversity of next generation antimalarial targets: A baseline for drug resistance surveillance programmes" [Int. J. Parasitol. Drugs and Drug Resist. 7 (2017) 174-180]. International journal for parasitology Drugs and drug resistance, 7 (3). 433-. ISSN 2211-3207 DOI: 10.1016/j.ijpddr.2017.11.001
Copy

The authors regret that the reported non-synonymous mutation L550V in the PfcPhers gene is a synonymous mutation. We would like to correct this information in the manuscript. In the Results section, second paragraph, it should read: “The L550V mutation was not identified in the set of global field isolates considered here. At this position we detected a synonymous mutation.” In the Discussion, second paragraph, this sentence can be omitted “From these observations, we speculate that for new antimalarial compounds acting on the PfcPhers gene, acquired resistance may occur more rapidly …”. L550V should be omitted from Tables 1 and 2 and Suppl. Table 1. The authors would like to apologies for any inconvenience caused.


picture_as_pdf
Corrigendum to Genetic diversity of next generation antimalarial targets.pdf
subject
Published Version
Available under Creative Commons: 3.0

View Download

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads